Halozyme Therapeutics, Inc. (HALO)
64.49
-0.91
(-1.39%)
USD |
NASDAQ |
Apr 02, 16:00
64.60
+0.11
(+0.17%)
Pre-Market: 08:15
Halozyme Therapeutics EPS Diluted (TTM) : 2.492 for Dec. 31, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Skye Bioscience, Inc. | -1.41 |
| Johnson & Johnson | 11.05 |
| Eli Lilly & Co. | 22.59 |
| Stryker Corp. | 8.398 |
| Glaukos Corp. | -3.271 |